Alberto Cordero

Amanecer en Alicante: cuando el sol pinta de oro el Mediterráneo. 🌅 ¿Eres de los que madrugan para ver esto? #Alicante #AlicanteCity #AlicanteTurismo

Association between atrial fibrillation and dementia in a large population-based study in southern Europe #REC #Aheadofprint @LoArLeCC @miguelcainzos23 @jrods91 @JosepComin @IgnasiAnguera revespcardiol.org/en-association…

👉  New Evidence: Lifetime Risk Starts Early 👆 A 22-year follow-up of young adults from the CARDIA study shows that cumulative exposure to apoB, LDL-P, and TRL-P between ages 18–40 significantly increases the risk of ASCVD events later in life. 📈 Each 1 SD increase in these…

Enhorabuena @asierleivar ! Muy buena entrevista con @elinares13 ! Cuantos buenos consejos ! open.spotify.com/episode/1b4Itp…

Ya disponible nuevo número de nuestra revista #latido 🆕 Monográfico▶️ manejo asistencial y prevención CV tras SCA ☑️ Gracias a los editores @SantasEnrique @miriamsandin y a todos los autores de @SVCardio ☑️ Con el apoyo de #AstraZeneca Descarga 🆓 en svcardio.org/latido

What's the optimal number of steps of physical activity that is associated with multiple (9) favorable outcomes? The largest, systematic review of 57 studies, 35 cohorts. 7,000 steps is clinically meaningful; some benefit also seen for 4,000 steps cf 2,000 steps @TheLancet…

⚠️ Antithrombotic drugs for ACS in women: sex-adjusted treatment and female representation in RCT. A clinical consensus statement of the EAPCI and the ESC Working Group on Thrombosis‼️ @secardiologia @SACardiologia @almucastro01 @OjedaOjeda18 @MAROSFO academic.oup.com/eurheartj/arti…

🫀 Cancer treatments save lives—but can damage the heart. 🚨New consensus from @escardio: How to prevent therapy-related heart failure in cancer patients & survivors📚 Cure cancer. Protect the heart. 👉 #CardioOncology #CancerSurvivorship #PositionPaper

Single-pill combination therapies could substantially accelerate progress on #CVD mortality by increasing use of preventive drugs, especially in settings where uptake is currently low. Read the journal scan to learn more: bit.ly/4kImQbK #cvLipids #JACC @JACCJournals

🖊️🖊️🖊️

📜Early anti-inflammatory therapy in acute MI: A network meta-analysis of timing-dependent effects in 23 randomized trials and 28,220 patients. 🙌Congrats to @BorjaRiversa and the whole team. @RaulmorenoMD @Mfvlorenzo @saldagar @shci_sec @secardiologia kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

Risk factors are rising, even as care improves. This global forecast reveals a syndemic of #CVD risk fueled by aging and growth 📊⚠️ 🔗 jacc.org/doi/10.1016/j.… #JACC #GBDstudy

Recurrent readmissions for heart failure: a persistent issue even in patients achieving stability #REC @JavierdeJuan1 @rsbodes @JuanFDelgado1 revespcardiol.org/en-recurrent-r…

Outcomes of Lesions With Discordance Between FFR and Nonhyperemic Pressure Ratios @JACCJournals "Deferral of PCI in discordant-physiology was associated with worse long-term outcomes. There may be a benefit of revascularization in FFR+/NHPRs− lesions" jacc.org/doi/10.1016/j.…

Maravilloso reportaje, sistema sanitario de vanguardia gracias a los impuestos que pagamos, que lo recordamos demasiado poco… Cuando el hospital se instala en el salón de casa: "Es maravilloso" diariodesevilla.es/sevilla/hospit… vía @diariosevilla

How democracy and inequality shaped the initial COVID-19 pandemic “the importance of social welfare provisions and healthcare systems in responding to large-scale disasters such as the COVID-19 pandemic” journals.sagepub.com/doi/10.1177/00…

🧵 HILO en 2 tuits ESPAÑA NO NECESITA MÁS MÉDICOS, NECESITA DEJAR DE MALTRATARLOS. Faltan especialistas, planificación, contratos dignos y respeto. Una vez más, brillante análisis de @vicentematas ⬇️ Imprescindible leer

Global Effect of Cardiovascular Risk Factors on Lifetime Estimates @NEJM “The absence of 5 classic risk factors at 50 was associated with more than a decade greater life expectancy than the presence of risk factors” nejm.org/doi/full/10.10…

Hot Lines of #Esccongress2025 have just been revealed!!! Come on @Borjaibanez1 @RoselloXavier and @RebootTrial !!! @escardio esc365.escardio.org/ESC-Congress/s…

Gene therapy and genome editing for lipoprotein disorders. A State-of-the-Art review just published in #EHJ 👉 ow.ly/sqqC50Wl1kQ @RoccoMontone @ehj_ed #dyslipidemia